[20191216]IF11389_FDA实验室开发试验(LDTs)法规.pdf

上传人:任我行 文档编号:28753 上传时间:2022-06-24 发布时间:2019-12-17 格式:PDF 页数:3 大小:428.87KB
下载 相关 举报
[20191216]IF11389_FDA实验室开发试验(LDTs)法规.pdf_第1页
第1页 / 共3页
[20191216]IF11389_FDA实验室开发试验(LDTs)法规.pdf_第2页
第2页 / 共3页
[20191216]IF11389_FDA实验室开发试验(LDTs)法规.pdf_第3页
第3页 / 共3页
亲,该文档总共3页,全部预览完了,如果喜欢就下载吧!
资源描述

1、 https:/crsreports.congress.gov December 16, 2019FDA Regulation of Laboratory-Developed Tests (LDTs)Laboratory-developed tests (LDTs) are a class of in vitro diagnostic (IVD) device that is designed, manufactured, and used within a single laboratory. LDTs are often used to test for conditions or dis

2、eases that are either rapidly changing (e.g., new strains of known infectious diseases) or that are the subject of quickly advancing scientific research (e.g., genomic testing for cancer). The majority of genetic testsa type of IVD that analyzes various aspects of an individuals genetic material (e.

3、g., DNA, RNA)are LDTs. Federal agencies involved in the regulation of LDTs include the Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS). FDA regulates the safety and effectiveness of the diagnostic test, as well as the quality of the design and manufacture of

4、 the diagnostic test, pursuant to authorities in the Federal, Food, Drug, and Cosmetic Act (FFDCA). CMS regulates the quality of clinical laboratories and the clinical testing process pursuant to the Clinical Laboratory Improvement Amendments of 1988 (CLIA). This In Focus addresses only FDAs role in

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告